Annual CFF
-$79.79 M
+$119.79 M+60.02%
31 December 2023
Summary:
Medifast annual cash flow from financing activities is currently -$79.79 million, with the most recent change of +$119.79 million (+60.02%) on 31 December 2023. During the last 3 years, it has fallen by -$22.64 million (-39.63%). MED annual CFF is now -990.10% below its all-time high of $8.96 million, reached on 31 December 2003.MED Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$3000.00
+$17.00 K+85.00%
30 September 2024
Summary:
Medifast quarterly cash flow from financing activities is currently -$3000.00, with the most recent change of +$17.00 thousand (+85.00%) on 30 September 2024. Over the past year, it has increased by +$18.15 million (+99.98%). MED quarterly CFF is now -100.04% below its all-time high of $8.19 million, reached on 30 September 2003.MED Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$19.42 M
+$18.15 M+48.31%
30 September 2024
Summary:
Medifast TTM cash flow from financing activities is currently -$19.42 million, with the most recent change of +$18.15 million (+48.31%) on 30 September 2024. Over the past year, it has increased by +$66.80 million (+77.48%). MED TTM CFF is now -316.63% below its all-time high of $8.96 million, reached on 31 December 2003.MED TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MED Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.0% | +100.0% | +77.5% |
| 3 y3 years | -39.6% | +100.0% | +81.9% |
| 5 y5 years | -49.6% | +100.0% | +74.3% |
MED Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -39.6% | +60.0% | at high | +100.0% | at high | +90.6% |
| 5 y | 5 years | -49.6% | +60.0% | at high | +100.0% | at high | +90.6% |
| alltime | all time | -990.1% | +60.0% | -100.0% | +100.0% | -316.6% | +90.6% |
Medifast Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3000.00(-85.0%) | -$19.42 M(-48.3%) |
| June 2024 | - | -$20.00 K(-98.7%) | -$37.57 M(-32.2%) |
| Mar 2024 | - | -$1.49 M(-91.7%) | -$55.38 M(-30.6%) |
| Dec 2023 | -$79.79 M(-60.0%) | -$17.91 M(-1.4%) | -$79.79 M(-7.5%) |
| Sept 2023 | - | -$18.15 M(+1.8%) | -$86.22 M(-23.8%) |
| June 2023 | - | -$17.84 M(-31.1%) | -$113.17 M(-42.7%) |
| Mar 2023 | - | -$25.90 M(+6.4%) | -$197.36 M(-1.1%) |
| Dec 2022 | -$199.58 M(+59.5%) | -$24.33 M(-46.1%) | -$199.58 M(-3.3%) |
| Sept 2022 | - | -$45.11 M(-55.8%) | -$206.48 M(+1.1%) |
| June 2022 | - | -$102.03 M(+262.8%) | -$204.32 M(+55.9%) |
| Mar 2022 | - | -$28.12 M(-10.0%) | -$131.03 M(+4.7%) |
| Dec 2021 | -$125.13 M(+119.0%) | -$31.23 M(-27.3%) | -$125.13 M(+16.9%) |
| Sept 2021 | - | -$42.95 M(+49.4%) | -$107.05 M(+38.5%) |
| June 2021 | - | -$28.74 M(+29.3%) | -$77.29 M(+17.8%) |
| Mar 2021 | - | -$22.22 M(+69.0%) | -$65.62 M(+14.8%) |
| Dec 2020 | -$57.14 M(-30.6%) | -$13.14 M(-0.3%) | -$57.14 M(-14.1%) |
| Sept 2020 | - | -$13.19 M(-22.8%) | -$66.54 M(-22.1%) |
| June 2020 | - | -$17.07 M(+24.2%) | -$85.41 M(-2.1%) |
| Mar 2020 | - | -$13.74 M(-39.0%) | -$87.25 M(+6.0%) |
| Dec 2019 | -$82.32 M(+54.4%) | -$22.54 M(-29.7%) | -$82.32 M(+8.8%) |
| Sept 2019 | - | -$32.06 M(+69.5%) | -$75.68 M(+53.7%) |
| June 2019 | - | -$18.91 M(+114.6%) | -$49.23 M(-12.3%) |
| Mar 2019 | - | -$8.81 M(-44.6%) | -$56.10 M(+5.2%) |
| Dec 2018 | -$53.33 M(+207.2%) | -$15.90 M(+183.6%) | -$53.33 M(+24.0%) |
| Sept 2018 | - | -$5.61 M(-78.3%) | -$43.02 M(+4.3%) |
| June 2018 | - | -$25.79 M(+327.2%) | -$41.23 M(+114.1%) |
| Mar 2018 | - | -$6.04 M(+8.1%) | -$19.26 M(+10.9%) |
| Dec 2017 | -$17.36 M(+34.4%) | -$5.59 M(+46.0%) | -$17.36 M(+13.4%) |
| Sept 2017 | - | -$3.83 M(+0.3%) | -$15.30 M(+5.6%) |
| June 2017 | - | -$3.81 M(-7.8%) | -$14.49 M(+7.7%) |
| Mar 2017 | - | -$4.13 M(+17.2%) | -$13.45 M(+4.1%) |
| Dec 2016 | -$12.92 M(+10.1%) | -$3.53 M(+16.9%) | -$12.92 M(+31.6%) |
| Sept 2016 | - | -$3.02 M(+8.8%) | -$9.82 M(-30.1%) |
| June 2016 | - | -$2.77 M(-23.0%) | -$14.05 M(-3.8%) |
| Mar 2016 | - | -$3.60 M(+745.5%) | -$14.61 M(+24.6%) |
| Dec 2015 | -$11.73 M(-66.4%) | -$426.00 K(-94.1%) | -$11.73 M(-4.3%) |
| Sept 2015 | - | -$7.25 M(+117.3%) | -$12.26 M(-50.4%) |
| June 2015 | - | -$3.33 M(+361.9%) | -$24.72 M(-30.6%) |
| Mar 2015 | - | -$722.00 K(-24.4%) | -$35.62 M(+1.9%) |
| Dec 2014 | -$34.94 M(+49.9%) | -$955.00 K(-95.2%) | -$34.94 M(-35.4%) |
| Sept 2014 | - | -$19.70 M(+38.4%) | -$54.05 M(+58.0%) |
| June 2014 | - | -$14.23 M(>+9900.0%) | -$34.20 M(+71.5%) |
| Mar 2014 | - | -$48.00 K(-99.8%) | -$19.95 M(-14.4%) |
| Dec 2013 | -$23.31 M(+697.0%) | -$20.07 M(<-9900.0%) | -$23.31 M(+766.7%) |
| Sept 2013 | - | $148.00 K(+604.8%) | -$2.69 M(-6.1%) |
| June 2013 | - | $21.00 K(-100.6%) | -$2.86 M(-52.8%) |
| Mar 2013 | - | -$3.42 M(-714.2%) | -$6.07 M(+107.7%) |
| Dec 2012 | -$2.92 M(-86.0%) | $556.00 K(-2238.5%) | -$2.92 M(-22.8%) |
| Sept 2012 | - | -$26.00 K(-99.2%) | -$3.79 M(-68.4%) |
| June 2012 | - | -$3.19 M(+1098.9%) | -$12.01 M(-44.0%) |
| Mar 2012 | - | -$266.00 K(-14.2%) | -$21.42 M(+2.5%) |
| Dec 2011 | -$20.90 M | -$310.00 K(-96.2%) | -$20.90 M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$8.24 M(-34.6%) | -$20.29 M(+78.3%) |
| June 2011 | - | -$12.61 M(-4986.4%) | -$11.38 M(-856.8%) |
| Mar 2011 | - | $258.00 K(-12.8%) | $1.50 M(+12.8%) |
| Dec 2010 | $1.33 M(-246.8%) | $296.00 K(-55.8%) | $1.33 M(+3.1%) |
| Sept 2010 | - | $670.00 K(+139.3%) | $1.29 M(+1305.4%) |
| June 2010 | - | $280.00 K(+221.8%) | $92.00 K(-113.1%) |
| Mar 2010 | - | $87.00 K(-66.0%) | -$704.00 K(-22.5%) |
| Dec 2009 | -$908.00 K(-162.1%) | $256.00 K(-148.2%) | -$908.00 K(-21.9%) |
| Sept 2009 | - | -$531.00 K(+2.9%) | -$1.16 M(+428.2%) |
| June 2009 | - | -$516.00 K(+341.0%) | -$220.00 K(-127.7%) |
| Mar 2009 | - | -$117.00 K(-5950.0%) | $795.00 K(-45.7%) |
| Dec 2008 | $1.46 M(+30.0%) | $2000.00(-99.5%) | $1.46 M(-17.9%) |
| Sept 2008 | - | $411.00 K(-17.6%) | $1.78 M(-11.8%) |
| June 2008 | - | $499.00 K(-9.4%) | $2.02 M(+40.6%) |
| Mar 2008 | - | $551.00 K(+71.7%) | $1.44 M(+27.7%) |
| Dec 2007 | $1.13 M(+123.7%) | $321.00 K(-50.6%) | $1.13 M(-26.4%) |
| Sept 2007 | - | $650.00 K(-864.7%) | $1.53 M(+121.3%) |
| June 2007 | - | -$85.00 K(-135.6%) | $691.00 K(-21.3%) |
| Mar 2007 | - | $239.00 K(-67.0%) | $878.00 K(+74.6%) |
| Dec 2006 | $503.00 K(-262.8%) | $725.00 K(-485.6%) | $503.00 K(-161.3%) |
| Sept 2006 | - | -$188.00 K(-284.3%) | -$821.00 K(+14.3%) |
| June 2006 | - | $102.00 K(-175.0%) | -$718.00 K(-25.5%) |
| Mar 2006 | - | -$136.00 K(-77.3%) | -$964.00 K(+212.0%) |
| Dec 2005 | -$309.00 K(+1.6%) | -$599.00 K(+604.7%) | -$309.00 K(-455.2%) |
| Sept 2005 | - | -$85.00 K(-41.0%) | $87.00 K(-302.3%) |
| June 2005 | - | -$144.00 K(-127.7%) | -$43.00 K(-110.3%) |
| Mar 2005 | - | $519.00 K(-355.7%) | $419.00 K(-237.8%) |
| Dec 2004 | -$304.00 K(-103.4%) | -$203.00 K(-5.6%) | -$304.00 K(-157.7%) |
| Sept 2004 | - | -$215.00 K(-167.6%) | $527.00 K(-94.1%) |
| June 2004 | - | $318.00 K(-255.9%) | $8.93 M(+4.7%) |
| Mar 2004 | - | -$204.00 K(-132.5%) | $8.53 M(-4.9%) |
| Dec 2003 | $8.96 M(+234.6%) | $628.00 K(-92.3%) | $8.96 M(+8.5%) |
| Sept 2003 | - | $8.19 M(<-9900.0%) | $8.27 M(+181.6%) |
| June 2003 | - | -$82.00 K(-135.5%) | $2.94 M(+0.9%) |
| Mar 2003 | - | $231.00 K(-425.4%) | $2.91 M(+8.5%) |
| Dec 2002 | $2.68 M(-895.0%) | -$71.00 K(-102.5%) | $2.68 M(+3.3%) |
| Sept 2002 | - | $2.86 M(-2721.1%) | $2.59 M(-667.6%) |
| June 2002 | - | -$109.00 K(-5550.0%) | -$457.00 K(+21.9%) |
| Mar 2002 | - | $2000.00(-101.3%) | -$375.00 K(+11.3%) |
| Dec 2001 | -$337.00 K(-215.0%) | -$156.00 K(-19.6%) | -$337.00 K(-179.2%) |
| Sept 2001 | - | -$194.00 K(+618.5%) | $425.50 K(+158.8%) |
| June 2001 | - | -$27.00 K(-167.5%) | $164.40 K(>+9900.0%) |
| Mar 2001 | - | $40.00 K(-93.4%) | $1000.00(-99.7%) |
| Dec 2000 | $293.00 K(+51.8%) | $606.50 K(-233.3%) | $293.00 K(-193.5%) |
| Sept 2000 | - | -$455.10 K(+139.0%) | -$313.50 K(-321.4%) |
| June 2000 | - | -$190.40 K(-157.3%) | $141.60 K(-57.3%) |
| Mar 2000 | - | $332.00 K(-166.0%) | $332.00 K(-166.0%) |
| Dec 1999 | $193.00 K(-92.2%) | - | - |
| Mar 1999 | - | -$503.00 K | -$503.00 K |
| Dec 1998 | $2.47 M(-648.6%) | - | - |
| Dec 1997 | -$451.00 K(-141.3%) | - | - |
| Dec 1996 | $1.09 M | - | - |
FAQ
- What is Medifast annual cash flow from financing activities?
- What is the all time high annual CFF for Medifast?
- What is Medifast annual CFF year-on-year change?
- What is Medifast quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Medifast?
- What is Medifast quarterly CFF year-on-year change?
- What is Medifast TTM cash flow from financing activities?
- What is the all time high TTM CFF for Medifast?
- What is Medifast TTM CFF year-on-year change?
What is Medifast annual cash flow from financing activities?
The current annual CFF of MED is -$79.79 M
What is the all time high annual CFF for Medifast?
Medifast all-time high annual cash flow from financing activities is $8.96 M
What is Medifast annual CFF year-on-year change?
Over the past year, MED annual cash flow from financing activities has changed by +$119.79 M (+60.02%)
What is Medifast quarterly cash flow from financing activities?
The current quarterly CFF of MED is -$3000.00
What is the all time high quarterly CFF for Medifast?
Medifast all-time high quarterly cash flow from financing activities is $8.19 M
What is Medifast quarterly CFF year-on-year change?
Over the past year, MED quarterly cash flow from financing activities has changed by +$18.15 M (+99.98%)
What is Medifast TTM cash flow from financing activities?
The current TTM CFF of MED is -$19.42 M
What is the all time high TTM CFF for Medifast?
Medifast all-time high TTM cash flow from financing activities is $8.96 M
What is Medifast TTM CFF year-on-year change?
Over the past year, MED TTM cash flow from financing activities has changed by +$66.80 M (+77.48%)